| License: Creative Commons Attribution Non-commercial 4.0 PDF - Published Version (17MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-445890
- DOI to cite this document:
- 10.5283/epub.44589
Abstract
The ability to detect low concentrations of analytes and in particular low‐abundance biomarkers is of fundamental importance, e.g., for early‐stage disease diagnosis. The prospect of reaching the ultimate limit of detection has driven the development of single‐molecule bioaffinity assays. While many review articles have highlighted the potentials of single‐molecule technologies for analytical and ...

Owner only: item control page